Blood Components and Transfusion Practice Flashcards

1
Q

Hemovigilance

A

Consists of the collection of information on the complications of transfusion, analysis of these data, and subsequent data-driven improvements in transfusion practices. Goal: to improve the reporting of transfusion-related adverse events.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why irradiate

A
  1. Premature Neonates <1200g 2. known or suspected cellular immunodeficiency 3. significant immunosuppression (chem/radiation) 4. components from blood relatives 5. HLA/crossmatched plt 6. Granulocytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How much radiation

A

1500 (for the entire bag) 2500 directed at the center of the bag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why perform exchange transfusion vs. simple transfusion

A

In sickle cell to prevent iron overload from multiple units transfused.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What time of patient has highest rate of alloimmunization

A

Sickle Cell Disease Patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How do you treat iron overload in neonates

A

Chelation therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why leukoreduce blood

A

decrease risk of CMV, decrease HLA alloimmunization, preven febrile nonhemolytic transfusion reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

volume reduction washing

A

decrease plasma in products for patients that cannot handle increased vascular volume (renal ischema, compromised heart function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Do units labeled Rh positive require confirmation testing of whole blood group

A

only require front type A and B, do not require Rh typing, D negative labeled however do require D typing (do not require weak D testing)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is cryoprecipitate made?

A

Must come from WB derived plasma, the plasma is frozen and then ‘slow thawed’ at 1-6 degrees. Certain elements are not soluble at 1-6 degrees and therefore precipitate. This is then cold centrifuged and the supernatant is pulled off the top leaving 10-15 mL.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Cryoprecipitate contains which factors?

A

Fibrinogen, Factor VIII, vWF, fibronectin, Factor XIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the requirements for Factor VIII quantity per bag

A

80 IU per bag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the requirement for quantity of fibrinogen in cryo bag?

A

150mg of fibronogen per bag.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Component preparation from WB 1st step

A

Red Cells step 1 soft spin, platelets are suspended in plasma (platelet rich plasma) and is transferred to a second bag, red cells remain in original bag and additive solution is added to bottom layer ( AS-1 AS-3 AS-5)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Component preparation from WB 2nd step

A

Platelets step 2 hard spin, this packs the platelets. platelets in one bag with 50-70mL plasma, supernatant plasma transferred to a different bag.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Component preparation from WB 3rd step

A

Plasma must be frozen, if frozen with 8 hours called FFP, if frozen within 24 hours PF24

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PF24

A

Plasma Frozen within 24 hours of phelebotomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

FFP

A

fresh frozen plasma, frozen within 8 hours of collection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Cryo production

A

Frozen Plasma (must be WB derived) thawed at 1-6c. Hard spin AT 1-6C, the cryo-reduced plasma transferred out leaving ~10-15mL in the cryo bag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Indications for Red Blood Cell Transfusion

A

to treat SYMPTOMATIC anemia in patients who need an increase of oxygen carrying capacity and red cell mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Typical Hgb levels for transfusion

A

<6g/dL usually requires transfusion >10g/dL usually does not require transfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Washed RBCs

A

prevent severe allergic reaction, to remove IgA in IgA deficient individuals or haptoglobin in haptoglobin deficient individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Frozen RBCs

A

for use in rare red cell units, or autologous units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Laboratory tests for platelet functin

A

platelet aggregation test, platelet count, NOT BLEEDING TIME

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Platelet contraindications

A

do not transfuse platelets to patient with conditions of rapid platelet destruction: ITP, DIC, HIT, TTP. definitely not HIT or TTP- could cause thrombosis, DIC is subjective depending on the level of clotting vs. bleeding, cryo is more appropriate. ITP does need platelet transfusions however the concern is recurring destruction and damage to spleen, in spleenectomy of these patients platelets can be given once the vascular pedicle is clamped

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

One does (1 apheresis or 5-6 pooled donors) will raise platelet count how much?

A

30-60k in an adult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Volume of apheresis platelet

A

200-400 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

QC requirement for platelet

A

3 x 10^11

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Advantages of apheresis platelet vs. pooled donor

A

can provide matched-HLA type, wouldn’t be able to find 5-6 donors in order to provide a full unit, also can reduce the donor exposure with number of HLA antigens/HNA/HPA the patient is exposed to.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Platelet transfusion count indications

A

10,000/uL standard in most places, 50,000uL in active bleed or surgical patients 100,000/uL in patients with intacerebral damage or surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

If thrombocytopenia is due to sepsis or fever

A

Platelet transfusion is largely ineffective, need to treat sepsis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

non-immune causes of Platelet refractory

A

massive bleeding, splenomegaly, fever, sepsis, DIC, drugs and patient related (chemo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

drugs that can cause platelet refractory

A

amphotericin B and vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

why is it important to give type specific or compatible platelets

A
  1. Because platelets carry ABH antigens, if an A platelet is given to an O patient, the anti-A in patient can destroy the platelets- not as much of a bump 2. Because Platelets have antibodies if you give an O platelet (with anti-A) to an A patient it could bind to red cells and DAT may be positive, hemolysis is pretty rare.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

platelet type to give baby

A

match the babies blood type, however if baby had HDN due to ABO antibodies (ex. anti-A from mom) you would want to give O platelets instead

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

platelet transfusions: bloody platelets

A

If Platelet has > 2mL of red cells- you must crossmatch, this will be grossly bloody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

platelets: Rh

A

there are not RH antigens on platelets, however, there are red cells in platelets, try not to give RH pos platelets to an Rh negative patient, could make anti-D (if unavoidable you can give RHIG- (in women of child-bearing age especially) 1 Rhig vial is enough to protect against D positive Red cells in 7 apheresis platelets or 30 individual platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Thawed plasma

A

FFP/PF24 thawed but not transfused within 24 hours can be relabeled to ‘thawed plasma’ All of these contain therapueutic clotting factors including V and VIII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Contraindications for plasma transfusion

A

Do not transfuse when coagulopathy can be corrected more effectively with specific therapy: factor concentrates, Cryo or vitamin K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Uses for plasma in transfusion

A
  1. Reversal of warfarin (second choice behind PCC) 2. massive transfusion 3. preoperative or bleeding patients with multiple factor deficiencies (liver diease, DIC, dilutional coagulopathy due to massive transfusion)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Dose of plasma

A

~10-15 ml/Kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

What percentage of factors are necessary for normal hemostasis?

A

40% of factors need to be present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

what volume of plasma has 100% factor activity

A

1 Liter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

how much does each FFP unit raise coagulation factors in adult

A

10% (if you think patients approx plasma volume ~3000, each plasma unit ~300 and each unit contains 100% factor this equals 10%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Liquid plasma

A

plasma separated any time up to 5 days AFTER expiration of the whole blood, stored at 1-6 degrees. Expiration: CPD=26 days CPD-A1 40 DAYS, indicated for treatment of massive hemmorhage. This is only good for 5 days after WB expiration date, if it’s separated 5 days after expiration it expires that same day.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Cryo reduced plasma

A

by product of cryo productin, deficient in fibrinogen, factor VIII, factor XIII, vWF, may be used in therapeutic exchange for TTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

recovered plasma

A

Includes plasma (frozen) and liquid plasma. unlicensed not for transfusion, expiration depend son short supply agreement, used for fractionation into albumin, AT-III, Factor VIII, IX, or immunoglobulin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Short supply agreement

A

When Recovered [] Plasma is to be used in licensed products, it must be shipped in full compliance with the provisions of 21 CFR 601.22 (Short Supply) by the short supplier (the initial manufacturer) or an authorized agent (the licensed manufacturer’s agent) solely to the manufacturer under whose license the short supplier or an authorized agent is on file. Recovered [] Plasma for use in manufacturing licensed products may be pooled by the short supplier if complete records, including donor numbers for each unit pooled, are maintained. Any product manipulated by an authorized agent cannot be shipped under the short supply provisions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

each unit of cryo typically has how much fibrinogen

A

~250mg/dL

50
Q

What is cryo used for

A

For Factor XIII and fibrinogen deficiency. Not used for Factor VIII deficiency or vWF when concentrates are available

51
Q

How much does cryo increase fibrinogen level

A

single unit (5-10 mg/dL) pooled pack of 5 (25-50mg/dL)

52
Q

Reasonable fibrinogen target for patient

A

150-200 mg/dL

53
Q

Granulocyte Transfusion indications

A

immunocompromised individual severe neutropenia (<500 granulocyte count), fever for 24-48 hours, bacterial/fungal culture positive, not responding to antibiotics myeloid hypoplasia, MUST HAVE REASONABLE CHANCE FOR RECOVERY, CGD during life-threatening epidsodes of infection. This is rarely used in adult patients.

54
Q

normal WBC

A

4.5-11 x10^9

55
Q

aPTT and PTT normal range

A

aPTT is the same test as PTT except an activator has been added, cutting the response time in half RR for aPTT is 30-40 seconds PTT is 60-70 seconds

56
Q

PT normal range

A

10-12 seconds

57
Q

Granulocyte collection

A

apheresis collection, donor is stimulated (G-CSF) for a larger yield side effect is musculoskeletal pain. collect 250-600mL, store at RT for 24 hours

58
Q

Acceptable granulocyte collection value QC

A

> /= 1 x10^10 granulocytes

59
Q

Setting up granulocytes on patient

A

unit needs to be irradiated, prevent TA-GVHD also crossmatch is required, it contains >2mL of red cells. When transfusing DO NOT use a leukoreduction filter, defeats the purpose. CMV- donor if indicated, since you cannot leukoreduce, if patient is alloimmunized use HLA-matched products

60
Q

Leukocyte reduction requirements

A

<5 x 10^6 residual WBCs per product- deemed by the FDA.

61
Q

Benefits of leukoreduction

A

Decrease risk of CMV infection/effects, decrease exposure to further antigens HNA, HLA, decrease febrile nonhemolytic reactions. It is an alternative to CMV sero-negative.

62
Q

Indications for leukoreduction

A
  1. immunocompromised patients (newborns, transplant recipents and patients with aplastic anemia) 2.recurrent febrile non-hemolytic transfusion reactions and 3. prevention of HLA alloimmunization.
63
Q

Irradiation importance

A

The only currently accepted method in the US for preventing TA-GVHD.

64
Q

classic cause of TA-GVHD

A

donor is homozygous, but recipient is heterozygous, does not recognize the homozygous as different because it matches one of it’s own, but the donor cells see the recipient as foreign.

65
Q

Irradiation amount and QC

A

must receive >25 centigrade to the midline of the bag, >15 centigrade to all other parts of the bag.

66
Q

AABB standards for irradiation

A
  1. patient is identified as being at risk for TA-GVHD 2. cellular units from the recipients blood relatives 3. donor is selected for HLA compatibility.
67
Q

Freezing and Deglycerolization of RBCs

A
  1. open system: unit expires within 24 hours of thaw stepwise decreasing osmolar solution of saline: 12% NaCl 1.6% NaCl .9% NaCl. 2. close system, expires in 14 days, must freeze and deglycerolize using the same system
68
Q

Deglycerolization of RBCs QC

A

cells must have >/= 80% recovery

69
Q

Deglycerizatin and sickle cell

A

sickel cell trait donors should not be frozen because there is major cell loss when deglycerolized with hypertonic wash solutions.

70
Q

expiration of deglycerized cells open system

A

24 hours

71
Q

expiration of deglycerized cells closed system

A

14 days

72
Q

Derivatives examples (6)

A

Albumin, Prothrombin Complex Concentrates (vitamin K dependent factors), IVIG, RHIG, Clotting factor concentrates (VIII and IX) and Antithrombin III

73
Q

cohn fractionation

A

The Cohn fractionation process originally developed in the 1940’s involved modifying the pH, the ethanol concentration and the temperature of the plasma to separate its proteins through precipitation into five “fractions” (I-V).

74
Q

derivatives processing

A

cohn fractionation and then further processed to purify and concentrate teh proteins using chemical solvent/detergent and affinity column

75
Q

Premature infant TBV

A

108

76
Q

Newborn infant TBV

A

87

77
Q

Blood administration filter

A

all blood components need to be filtered using standard filter (170-260 microns)

78
Q

Venous access gauge, in adults and chilren

A

adults: 18-20 gauge children 22-24 gauge

79
Q

Standards for Physcian orders

A

must order component preparation from blood bank, then must order transfusion, including premedication or component modifications

80
Q

Prior to transfusion checks

A

verify MD order, two independent recipient identifiers, component number, abo and rh check of both the unit and the recipient. Component tag must stay attached during the transfusion! Component check: check the experience of hemolysis clots, and color, also check the expiration date

81
Q

IV solutions

A

0.9% sodium chloride, normosol-R pH 7.4, plasma lyte A, pH 7.4. Plama-Lyte 148

82
Q

Must do’s during transfusion

A

Begin unit slowly 2mL/min and check vitals at 15 minutes. After 15 minutes you may increase the transfusion rate, monitor vitals periodically until transfusion is complete, must complete transfusion within 4 hours

83
Q

Pathogen inactivation

A

Inactivates viruses bacteria, spirochetes, parasites and leukocytes. T cells are reduced to a level that potentially lowers the risk of TA-GVHD.

84
Q

Bacterial Detection of platelets

A

Without pathogen inactivation, detection must be culture based. 1. Pall eBDS:surrogate marker of oxygen concentration 2. BacT alert surrogate marker=CO2 3. verax PGD, 30 minutes bench top quantitative immunoassay

85
Q

How long is blood good for post irradiation

A

28 days or original unit expiration date whichever is shorter

86
Q

Number of WBCs required for blood to be considered leukoreduced

A

5 x 10^6 (normal WBC ct in unit is 5x10^9)

87
Q

When transfusing blood to patient, what does the clerical information listed on the recipent transfusion tag get compared to?

A

The hospital issued wristband on the patient.

88
Q

What two things must the blood request form contain?

A

Patient unique ID number and First and Last name

89
Q

Should draw the patients blood only after what?

A

Verifying the patients identity by the wristband, or the patient providing their name and dob. Should not use the name on the bed or chart as this may not be the correct patient.

90
Q

In babies how old of blood can be provided

A

As fresh as possible and no older than 7 days

91
Q

Massive Transfusion definition

A

8-10 RBC units in 24 hours or 4-5 units in 1 hour

92
Q

Massive tranfusion in patient with antibody

A

Once blood volume has been surpassed there should be a work-around to shorten the pre-transfusion testing time on the units, no longer have to provide antigen negative until bleeding has significantly slowed down, at this point patient’s titer can increase and they may hemolyze donor cells that have the antigen

93
Q

Counteracting the effects of heparin

A

protamine sulfate

94
Q

Autologous units- testing on the unit

A

Must test the ABO and RH groups but does not need infectious disease testing or tests for unexpected antibodies-when blood is used within the collecting facility. Unit must be labeled ‘For autologous use only”

95
Q

In vivo compatibility of donor units can be measured by:

A

Labeling with radioactive (technetium)TC-99M or CR51 (chromium), blood transfused slowly and patient monitored closely, can later measure how much of RBC survived in patient with radioactive labels

96
Q

MSBOS

A

maximum surgical blood ordering schedule- was developed in order to better track what surgeries should or should not be ordering blood and how many units. Helps to prevent wastage of additional units that did not need to be ordered.

97
Q

After pretransfusion testing has been completed what two records must be prepared?

A

A statement of compatibility must be retained as part of the patient’s permanent medical record-if blood is transfused. A second label or tie tag must be attached to the unit stating the intended recipients identity, the pretransfusion testing results and the donor unit number-this tag must remain on unit until after completion of the transfusion.

98
Q

RFID

A

radio frequency identificaion, contains specific informatin that can be used for tracking and to communicate teh specific information. For example patient wristbands that contain the patient MRN and name can be scanned via barcode and transmitted to a computer system.

99
Q

How many times the information need to be reviewed as the clerical check at patient bedside prior to transfusion

A

at least twice. i.e. initial read and then ‘read back’ verification, two different sets of eyes.

100
Q

cannot accept unit back into inventory after issue if temperature is:

A

less than 1 degree C or above 10 degree C

101
Q

prestorage leukoreduction gets rid of how many WBCs from original product

A

99.9%

102
Q

WB hct

A

38%

103
Q

Ideal hct for RBC unit

A

less than 80% (80% maximum)

104
Q

HgB of final RBC unit

A

50-80g

105
Q

Irradiation sources

A

Cesium 137 and cobalt 60

106
Q

Final RBCs volume

A

typically 160-275mL in bag

107
Q

used for volume expansion

A

saline, albumin and plasma

108
Q

platelets, WBCs and clotting factors in WB

A

they don’t survive, this is why whole blood is not used much anymore

109
Q

Testing for syphillis-why

A

Serological test for syphillis is done because it is associated with increased risk of HIV and Hepatitis if possible

110
Q

How many cases of transfusion associated transmission of syphillis

A

three ever, doesn’t survive in citrated blood in 1-6 degrees for 72 hours- most likely transmission from platelets

111
Q

RPR what it is

A

rapid plasma reagin -syphilis test

112
Q

VDRL what it is

A

venereal disease research laboratory- syphillis test

113
Q

Screening tests for syphilis

A

RPR and VDRL, both based off reagin or antibodies toward cardiolipin particles. Present in people with untreated syphillis infections. will agglutinate show visible flocculation.

114
Q

Confirmatory test

A

FTA-ABS fluorescent treponemal antibody adsorption test, immmunoflourescence is used to detect antibodies to spirochette T. Pallidium.

115
Q

If screening test is positive for syphillis

A

confirmatory test is then performed. negative confirmatory test- donor reentered and units labeled with reactive screening test. If positive unit is discarded and may be reentered after 12 months and documentation of completed treatment

116
Q

If platelets are pooled within 4 hours of transfusion what testing is appropriate for bacterial testing

A

PGD- bacterial test, pregnancy test prior to releasing- testing 45 minutes can be performed at transfusion center

117
Q

If platelets are prepooled what testing is appropriate for bacterial testing

A

culture based testing.

118
Q

Steps if unit is positive for bacteria

A

quarantine and discard. If already issued need to recall and recipients physician is notified

119
Q

RR of T. cruzii antibodies

A

indefinitely deferred all unit destroyed, there are currently no method for reentry as no confirmatory testing exists

120
Q

If donor is positive for T. Cruzii antibodies

A

units must be discarded- “look back” to donations from the past 10 years on this donor, if donor had previously nonreactive test “look back” 12 months previous to the nonreactive test result

121
Q

T. Cruzii testing- reasoning, amount of testing

A

If donor is testing and nonreactive no further testing needs to be done in future donation. most people in the US that are positive are chronically positive from previously living in endemic country

122
Q

Random donor platelets should contain:

A

5.5 x 10^10 plts per unit